• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估异基因造血干细胞移植后肠道病毒/鼻病毒呼吸道感染的免疫缺陷评分指数表现。

Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.

机构信息

Department of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.

Department of Hematology, Hospital Universitari I Politècnic la Fe, Valencia, Spain.

出版信息

Transpl Infect Dis. 2020 Aug;22(4):e13301. doi: 10.1111/tid.13301. Epub 2020 May 23.

DOI:10.1111/tid.13301
PMID:32363665
Abstract

BACKGROUND

Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT).

OBJECTIVE

We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers.

RESULTS

We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant.

CONCLUSIONS

Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.

摘要

背景

肠病毒/鼻病毒(EvRh)是异基因造血干细胞移植(allo-HSCT)受者中呼吸道病毒感染的最常见原因。

目的

我们旨在分析免疫缺陷评分指数(ISI)在预测西班牙两个移植中心于 2013 年 12 月 1 日至 2019 年 12 月 1 日期间连续接受 allo-HSCT 的成年(>16 岁)EvRh 感染患者中,下呼吸道疾病(LRTD)进展和死亡率方面的价值。

结果

我们纳入了 234 例 allo-HSCT 受者,共发生 383 例 EvRh 感染。在 383 例 EvRh 感染中,98 例(25%)发生了 LRTD。多变量逻辑回归分析确定了与 LRTD 进展相关的三个独立因素:IgG<400mg/dL、社区获得性呼吸道病毒(CARV)合并感染和高危 ISI。IgG 水平和 CARV 合并感染纳入 ISI 后,显著提高了其性能,使得接受者操作特征曲线(AUROC)下面积从 0.643 增加到 0.734(P=0.03)。同样,多变量分析确定的与死亡率较高相关的两个条件是高危 ISI 和移植后 6 个月内的 EvRh 感染。

结论

我们的研究结果证实了高危 ISI 对预测 EvRh LRTD 概率和 3 个月总死亡率均有价值。我们还证明,通过纳入其他变量,可以对原始 ISI 进行调整,以提高其性能。

相似文献

1
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.评估异基因造血干细胞移植后肠道病毒/鼻病毒呼吸道感染的免疫缺陷评分指数表现。
Transpl Infect Dis. 2020 Aug;22(4):e13301. doi: 10.1111/tid.13301. Epub 2020 May 23.
2
Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.异基因造血干细胞移植受者呼吸道病毒感染后肺侵袭性真菌病的发病率、危险因素及转归
Transpl Infect Dis. 2019 Oct;21(5):e13158. doi: 10.1111/tid.13158. Epub 2019 Sep 3.
3
Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.热带地区中心异基因造血干细胞移植后的呼吸道病毒感染:免疫缺陷评分指数的预测价值
Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12693. Epub 2017 Apr 27.
4
Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.异基因造血干细胞移植受者社区获得性呼吸道病毒下呼吸道疾病:肺病毒-细菌混合感染的危险因素及死亡率
Transpl Infect Dis. 2018 Aug;20(4):e12926. doi: 10.1111/tid.12926. Epub 2018 Jun 22.
5
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.异基因造血干细胞移植后呼吸道合胞病毒和人偏肺病毒:免疫缺陷评分指数、病毒载量和利巴韦林治疗对结局的影响。
Transpl Infect Dis. 2020 Aug;22(4):e13276. doi: 10.1111/tid.13276. Epub 2020 Apr 6.
6
Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease.同种异体干细胞移植受者中,是否有特定的呼吸道病毒比其他病毒更严重?以下将重点关注下呼吸道疾病。
Bone Marrow Transplant. 2024 Aug;59(8):1118-1126. doi: 10.1038/s41409-024-02304-4. Epub 2024 May 10.
7
Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植受者的季节性人冠状病毒呼吸道感染。
J Infect Dis. 2021 May 20;223(9):1564-1575. doi: 10.1093/infdis/jiaa553.
8
The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.在异基因造血干细胞移植中建立前瞻性临床社区获得性呼吸道病毒监测计划的临床获益。
J Infect. 2020 Mar;80(3):333-341. doi: 10.1016/j.jinf.2019.12.022. Epub 2020 Jan 20.
9
Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.血液系统恶性肿瘤成人患者呼吸道合胞病毒下呼吸道感染后死亡的危险因素。
Transpl Infect Dis. 2018 Dec;20(6):e12994. doi: 10.1111/tid.12994. Epub 2018 Sep 21.
10
Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients.造血干细胞移植受者下呼吸道的人鼻病毒感染
Transpl Infect Dis. 2013 Oct;15(5):474-86. doi: 10.1111/tid.12111. Epub 2013 Jul 25.

引用本文的文献

1
Is There a Role for Immunostimulant Bacterial Lysates in the Management of Respiratory Tract Infection?免疫刺激细菌裂解物在呼吸道感染治疗中的作用?
Biomolecules. 2024 Oct 2;14(10):1249. doi: 10.3390/biom14101249.
2
Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后腺病毒肺炎的临床表现、预后因素和转归。
Virol J. 2024 May 14;21(1):110. doi: 10.1186/s12985-024-02383-1.
3
Clinical Outcomes of Human Rhinovirus/Enterovirus Infection in Pediatric Hemopoietic Cell Transplant Patients.
小儿造血干细胞移植患者人鼻病毒/肠道病毒感染的临床结局
J Pediatric Infect Dis Soc. 2024 Jan 29;13(1):75-83. doi: 10.1093/jpids/piad106.